PMA device
Cerene® Cryotherapy Device
Channel Medsystems, Inc. · Device, Thermal Ablation, Endometrial (MNB, Class III) · First FDA decision Mar 28, 2019, newest Jul 8, 2026Uterine fibroids and heavy menstrual bleeding
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
2
Naming "Cerene Cryotherapy"
MAUDE reports
45
Brand "Cerene Cryotherapy", since 2015
PubMed studies
3
Mentioning "Cerene Cryotherapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cerene® Cryotherapy Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Cerene® Cryotherapy DevicePMA supplement
P180032-S023 · Decided Jul 8, 2026 · 26 days after receipt · Normal 180 Day Track
Device type: Device, thermal ablation, endometrial (MNB) · Obstetrics & Gynecology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cerene Cryotherapy", any status and sponsor, newest update first.
Channel MedsystemsNot on our public-company list
NCT05922657 · 300 participants (planned) · Start Jun 9, 2023 · Primary completion Dec 31, 2027
Device: Cerene · For: Heavy Menstrual Bleeding; Abnormal Uterine Bleeding; Menorrhagia
Sites: West Orange, New Jersey; Cincinnati, Ohio
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cerene Cryotherapy", and for the whole product code for context.
This brand
45 reports: 28 malfunction, 17 injury, 0 death
Whole product code MNB
2,839 reports: 909 malfunction, 1,913 injury, 13 death
Newest reports for this brand
3012018285-2026-00003 · Received Sep 24, 2026 · Event dated Aug 14, 2026
Device type: Device, Thermal Ablation, Endometrial (MNB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Intermenstrual Bleeding; Pelvic Pain
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1584-2025 · Started Mar 20, 2025 · Posted by FDA Apr 16, 2025
Reason given: Due to evaporator gasket not sealing which can cause liquid nitrous oxide to drip/leak from the bottom of the device handle during treatment or after treatment during venting of the device
Cause as FDA categorized it: Under Investigation by firm · Device type: Device, Thermal Ablation, Endometrial (MNB)
Published research
The most relevant PubMed records for "Cerene Cryotherapy"[tiab]. The summary above synthesizes these.
- Endometrial Cryoablation for the Treatment of Heavy Menstrual Bleeding: 36-Month Outcomes from the CLARITY Study.
Curlin HL, Anderson TL · Int J Womens Health · 2022
- Hysteroscopic Access and Uterine Cavity Evaluation 12 Months after Endometrial Ablation with the Cerene Cryotherapy Device.
Curlin H, Cholkeri-Singh A, Leal JGG, et al. · J Minim Invasive Gynecol · 2022Multicenter Study, Research Support, Non-U.S. Gov't
- A Prospective, Multicenter, Clinical Trial Evaluating the Safety and Effectiveness of the Cerene Device to Treat Heavy Menstrual Bleeding.
Curlin HL, Cintron LC, Anderson TL · J Minim Invasive Gynecol · 2021Clinical Trial, Multicenter Study
Other devices of this type
Also filed under product code MNB.
- NovaSure Impedance Controlled Endometrial Ablation SystemHologic, Inc. · PMA 2022
- Genesys HTA SystemAxora Medical, Inc. · PMA 2022
- Minerva Endometrial Ablation SystemAxora Medical, Inc. · PMA 2025
- Mara Water Vapor Ablation SystemCooperSurgical, Inc. · PMA 2023
- Hydro Thermablator Endometrial Ablation SystemAxora Medical, Inc. · PMA 2020
- Her Option Cryoablation Therapy SystemCooperSurgical, Inc. · PMA 2011
- Minitouch 3.8 Era System (Minitouch System)Microcube, LLC · PMA 2026
- AEGEA Vapor SystemCooperSurgical, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.